Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • COVID-19

Pandemic costs not yet estimated

    • General Internal Medicine
    • Infectiology
    • News
    • Prevention and health care
    • RX
  • 2 minute read

The Corona pandemic still has us in its clutches – with immense implications for the health of the body and mind, as well as for healthcare costs. The Federal Council has adopted an initial report. However, more precise data are still lacking for an exact quantitative assessment.

The Federal Council was asked to study the financial impact of the Corona pandemic on health care stakeholders. This includes the healthcare costs incurred by the federal government, cantons and insurers as well as those insured under the mandatory health insurance scheme (OKP) as a result of the pandemic. In addition, the effects on the premiums and reserves of the insurers of the OKP will be considered. A first interim report has been prepared, which contains an initial, mainly qualitative overview of the pandemic-related health care costs per cost unit. Because the pandemic is still ongoing and due to the usual time delay for data collection and processing, reliable data are currently only available to a limited extent. Quantitative statements are therefore only possible to a limited extent. In 2020, CHF 428 million was spent on the procurement of medical supplies (including logistics) and CHF 190 million on the procurement of vaccines (including logistics). For 2021, CHF 1.2 billion is budgeted for the procurement of medical supplies and vaccinations. This amount is specifically earmarked for the procurement of Covid-19 vaccines. Federal spending in 2020 for bills already received was CHF 194 million. An additional CHF 2.4 billion has been budgeted for analyses in 2021. An average day of treatment for a Covid 19 patient in a hospital bed unit was estimated to cost between CHF 1556-1778; with intensive care in the ICU, the average day of treatment per patient cost between CHF 3556-4444. The cantons’ share is at least 55%. Accordingly, the estimated inpatient costs for the cantons for 2020 range between approximately CHF 284 and 335 million. However, care must be taken when dealing with this information. The figures given here are rough estimates and not exact values.

Because the pandemic is ongoing, much of the information and data needed to respond to the postulate will not be available until a much later date. The question of the healthcare costs caused by the pandemic can only be answered conclusively once the pandemic has ended and the necessary data have been collected and evaluated. At present, the uncertainties are too great to be able to estimate all the financial implications for the entire healthcare system. Another report is to follow by the end of 2022.

Source, “Impact of Covid 19 Pandemic on Healthcare Payers,” 04/21/2021. Available at: www.bag.admin.ch/bag/de/home.html

 

CARDIOVASC 2021; 20(4): 40 (published 1/12/21, ahead of print).
InFo NEUROLOGY & PSYCHIATRY 2021, 19(6): 40.

 

Autoren
  • Leoni Burggraf
Publikation
  • CARDIOVASC
Related Topics
  • CORONA
  • Costs
  • covid
Previous Article
  • Dementia

Clarification in practice

  • CME continuing education
  • Education
  • Geriatrics
  • Neurology
  • Psychiatry and psychotherapy
  • RX
  • Studies
View Post
Next Article
  • Wound Management

Successfully treat venous leg ulcer with compression therapy

  • Dermatology and venereology
  • Education
  • Endocrinology and Diabetology
  • Phlebology
  • RX
  • Traumatology and trauma surgery
View Post
You May Also Like
View Post
  • 10 min
  • Neuropathic Pain

Evidence-Based Neuromodulation Based on Clinical Trials and Real-World Data

    • RX
    • CME continuing education
    • Neurology
    • Physical medicine and rehabilitation
    • Studies
    • Surgery
View Post
  • 14 min
  • Fibromyalgia Syndrome

Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity

    • General Internal Medicine
    • CME continuing education
    • Geriatrics
    • Neurology
    • Orthopedics
    • Rheumatology
    • RX
View Post
  • 7 min
  • Juvenile Idiopathic Arthritis

Early Detection and Targeted Treatment in an Interdisciplinary Setting

    • RX
    • Education
    • General Internal Medicine
    • Pediatrics
    • Rheumatology
View Post
  • 6 min
  • Disorders of the Gut-Brain Interaction

Rome V Criteria: What Has Changed, and What Has Remained the Same?

    • RX
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
View Post
  • 5 min
  • Tourette Syndrome

What can be done to treat this tic disorder?

    • RX
    • Education
    • General Internal Medicine
    • Neurology
    • Pharmacology and toxicology
    • Studies
View Post
  • 4 min
  • Chronic Hepatitis B: Is a Cure in Sight?

Phase III Trial of Temporary Treatment with Bepirovirsen Was Successful

    • RX
    • Congress Reports
    • General Internal Medicine
    • Infectiology
    • Studies
View Post
  • 9 min
  • Congenital Vascular Malformations

Personalized Treatment Before a Planned Pregnancy

    • Cardiology
    • Angiology
    • CME continuing education
    • General Internal Medicine
    • Genetics
    • Gynecology
    • Radiology
    • Surgery
View Post
  • 14 min
  • Fibromyalgia Syndrome

Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity

    • General Internal Medicine
    • CME continuing education
    • Geriatrics
    • Neurology
    • Orthopedics
    • Rheumatology
    • RX
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Evidence-Based Neuromodulation Based on Clinical Trials and Real-World Data
  • 2
    Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity
  • 3
    Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity
  • 4
    Personalized Treatment Before a Planned Pregnancy
  • 5
    Update on Anti-Rheumatic Medications

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.